Wednesday, March 28, 2018 Reminder: Feedback request on Health Canada Guidance GUI-0100 due April 2, 2018 As per the CCTG Bulletin February 28, 2018, feedback to the Health Canada draft of GUI-0100: Guidance Document – Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human Subjects.” is due to CCTG by April 2, 2018. Feedback can be sent to guidancefeedback@ctg.queensu.ca. Please see the Health Canada Notice of Consultation and English and French guidance documents at the following links: https://www.canada.ca/en/health-canada/programs/consultation-drugs-clinical-trials-involving-human-subjects.html English draft Guidance Document Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human Subjects” French draft Document d’orientation: Titre 5 de la partie C du Règlement sur les aliments et drogues - «Drogues destinèes aux essais cliniques sur des sujets humains» Please email feedback to guidancefeedback@ctg.queensu.ca
